Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02673034
Recruitment Status : Completed
First Posted : February 3, 2016
Last Update Posted : October 9, 2017
Sponsor:
Information provided by (Responsible Party):
Peter Humaidan, Regionshospitalet Viborg, Skive

Brief Summary:
The aim of the study is to investigate the circadian variation in serum-progesterone in women undergoing controlled ovarian stimulation.

Condition or disease
Infertility

Layout table for study information
Study Type : Observational
Actual Enrollment : 10 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.
Actual Study Start Date : December 2014
Actual Primary Completion Date : December 2015
Actual Study Completion Date : January 2016

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. serum progesterone levels [ Time Frame: 12 hours ]

Secondary Outcome Measures :
  1. serum LH levels [ Time Frame: 12 hours ]
  2. serum estradiol levels [ Time Frame: 12 hours ]
  3. 17-OH progesterone [ Time Frame: 12-hours ]

Biospecimen Retention:   Samples Without DNA
Serum


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Women undergoing IVF-treatment using either GnRHa long protocol or GnRH antagoinst co-treatment.
Criteria

Inclusion Criteria:

Women undergoing standard IVF/ICSI treatment.

Exclusion Criteria:

Previous participation in the study.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02673034


Locations
Layout table for location information
Denmark
The Fertility Clinic Skive
Skive, Resenvej 25, Denmark, 7800
Sponsors and Collaborators
Regionshospitalet Viborg, Skive

Layout table for additonal information
Responsible Party: Peter Humaidan, Professor, DMSc, Regionshospitalet Viborg, Skive
ClinicalTrials.gov Identifier: NCT02673034     History of Changes
Other Study ID Numbers: CirProg
First Posted: February 3, 2016    Key Record Dates
Last Update Posted: October 9, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Infertility
Ovarian Hyperstimulation Syndrome
Genital Diseases, Male
Genital Diseases, Female
Ovarian Diseases
Adnexal Diseases
Gonadal Disorders
Endocrine System Diseases
Progesterone
Progestins
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs